Recent advances in the diagnostic evaluation of pancreatic cystic lesions

Figure 1 Current standard of care diagnostic methods are suboptimal in the diagnosis of specific types of pancreatic cystic lesions and risk-stratification of mucinous cysts. PCL: Pancreatic cystic lesion, CEA: Carcinoembryonic antigen, IPMN: Intraductal papillary mucinous neoplasms, MCN: Mucinous cystic neoplasm, SPN: Solid pseudopapillary neoplasm, Cystic-NET: Cystic neuroendocrine tumors, SCA: Serous cystadenoma.

Figure 2 Features identified on endoscopic ultrasound guided needle confocal laser endomicroscopy. IPMN: Intraductal papillary mucinous neoplasms.

Figure 3 Future directions of detection and risk stratification of pancreatic cystic lesion to guide clinical management. PCL: Pancreatic cystic lesion, CEA: Carcinoembryonic antigen, IPMN: Intraductal papillary mucinous neoplasms.